ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antidiabetic Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-10G8630
Home | Market Reports | Health| Pharmacy| Drugs & Medications
China Antidiabetic Drug Market Report Forecast 2021 2027
BUY CHAPTERS

Global Antidiabetic Drug Market Research Report 2025

Code: QYRE-Auto-10G8630
Report
September 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol–Myers Squibb
Pfizer Inc
Tonghua Dongbao
Biocon Ltd.
WOCKHARDT

Antidiabetic Drug Market Size

The global market for Antidiabetic Drug was valued at US$ 54070 million in the year 2024 and is projected to reach a revised size of US$ 104420 million by 2031, growing at a CAGR of 10.0% during the forecast period.

Antidiabetic Drug Market

Antidiabetic Drug Market

Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antidiabetic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetic Drug.
The Antidiabetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antidiabetic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antidiabetic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antidiabetic Drug Market Report

Report Metric Details
Report Name Antidiabetic Drug Market
Accounted market size in year US$ 54070 million
Forecasted market size in 2031 US$ 104420 million
CAGR 10.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Alpha-Glucosidase Inhibitors
  • Biguanides, Sulphonylureas
  • Glp-1 Agonist
  • Meglitinides
  • Dpp-4 Inhibitors
  • Sglt–2
  • Thiazolodinediones
Segment by Application
  • Type I Diabetes
  • Type II Diabetes
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi-Aventis, Eli Lilly, Oramed, Takeda, Boehringer Ingelheim, Novo Nordisk, Halozyme Therapeutics, Bristol-Myers Squibb, Pfizer, Tonghua Dongbao, Biocon, Wockhardt
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antidiabetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antidiabetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Antidiabetic Drug Market growing?

Ans: The Antidiabetic Drug Market witnessing a CAGR of 10.0% during the forecast period 2025-2031.

What is the Antidiabetic Drug Market size in 2031?

Ans: The Antidiabetic Drug Market size in 2031 will be US$ 104420 million.

Who are the main players in the Antidiabetic Drug Market report?

Ans: The main players in the Antidiabetic Drug Market are Sanofi-Aventis, Eli Lilly, Oramed, Takeda, Boehringer Ingelheim, Novo Nordisk, Halozyme Therapeutics, Bristol-Myers Squibb, Pfizer, Tonghua Dongbao, Biocon, Wockhardt

What are the Application segmentation covered in the Antidiabetic Drug Market report?

Ans: The Applications covered in the Antidiabetic Drug Market report are Type I Diabetes, Type II Diabetes

What are the Type segmentation covered in the Antidiabetic Drug Market report?

Ans: The Types covered in the Antidiabetic Drug Market report are Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, Glp-1 Agonist, Meglitinides, Dpp-4 Inhibitors, Sglt–2, Thiazolodinediones

1 Antidiabetic Drug Market Overview
1.1 Product Definition
1.2 Antidiabetic Drug by Type
1.2.1 Global Antidiabetic Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Alpha-Glucosidase Inhibitors
1.2.3 Biguanides, Sulphonylureas
1.2.4 Glp-1 Agonist
1.2.5 Meglitinides
1.2.6 Dpp-4 Inhibitors
1.2.7 Sglt–2
1.2.8 Thiazolodinediones
1.3 Antidiabetic Drug by Application
1.3.1 Global Antidiabetic Drug Market Value by Application (2024 VS 2031)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Antidiabetic Drug Market Size Estimates and Forecasts
1.4.1 Global Antidiabetic Drug Revenue 2020-2031
1.4.2 Global Antidiabetic Drug Sales 2020-2031
1.4.3 Global Antidiabetic Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antidiabetic Drug Market Competition by Manufacturers
2.1 Global Antidiabetic Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antidiabetic Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antidiabetic Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antidiabetic Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antidiabetic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antidiabetic Drug, Product Type & Application
2.7 Global Key Manufacturers of Antidiabetic Drug, Date of Enter into This Industry
2.8 Global Antidiabetic Drug Market Competitive Situation and Trends
2.8.1 Global Antidiabetic Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antidiabetic Drug Players Market Share by Revenue
2.8.3 Global Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antidiabetic Drug Market Scenario by Region
3.1 Global Antidiabetic Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antidiabetic Drug Sales by Region: 2020-2031
3.2.1 Global Antidiabetic Drug Sales by Region: 2020-2025
3.2.2 Global Antidiabetic Drug Sales by Region: 2026-2031
3.3 Global Antidiabetic Drug Revenue by Region: 2020-2031
3.3.1 Global Antidiabetic Drug Revenue by Region: 2020-2025
3.3.2 Global Antidiabetic Drug Revenue by Region: 2026-2031
3.4 North America Antidiabetic Drug Market Facts & Figures by Country
3.4.1 North America Antidiabetic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antidiabetic Drug Sales by Country (2020-2031)
3.4.3 North America Antidiabetic Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antidiabetic Drug Market Facts & Figures by Country
3.5.1 Europe Antidiabetic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antidiabetic Drug Sales by Country (2020-2031)
3.5.3 Europe Antidiabetic Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antidiabetic Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Antidiabetic Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antidiabetic Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Antidiabetic Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antidiabetic Drug Market Facts & Figures by Country
3.7.1 Latin America Antidiabetic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antidiabetic Drug Sales by Country (2020-2031)
3.7.3 Latin America Antidiabetic Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antidiabetic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Antidiabetic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antidiabetic Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antidiabetic Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antidiabetic Drug Sales by Type (2020-2031)
4.1.1 Global Antidiabetic Drug Sales by Type (2020-2025)
4.1.2 Global Antidiabetic Drug Sales by Type (2026-2031)
4.1.3 Global Antidiabetic Drug Sales Market Share by Type (2020-2031)
4.2 Global Antidiabetic Drug Revenue by Type (2020-2031)
4.2.1 Global Antidiabetic Drug Revenue by Type (2020-2025)
4.2.2 Global Antidiabetic Drug Revenue by Type (2026-2031)
4.2.3 Global Antidiabetic Drug Revenue Market Share by Type (2020-2031)
4.3 Global Antidiabetic Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antidiabetic Drug Sales by Application (2020-2031)
5.1.1 Global Antidiabetic Drug Sales by Application (2020-2025)
5.1.2 Global Antidiabetic Drug Sales by Application (2026-2031)
5.1.3 Global Antidiabetic Drug Sales Market Share by Application (2020-2031)
5.2 Global Antidiabetic Drug Revenue by Application (2020-2031)
5.2.1 Global Antidiabetic Drug Revenue by Application (2020-2025)
5.2.2 Global Antidiabetic Drug Revenue by Application (2026-2031)
5.2.3 Global Antidiabetic Drug Revenue Market Share by Application (2020-2031)
5.3 Global Antidiabetic Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Company Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi-Aventis Antidiabetic Drug Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly Antidiabetic Drug Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Oramed
6.3.1 Oramed Company Information
6.3.2 Oramed Description and Business Overview
6.3.3 Oramed Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Oramed Antidiabetic Drug Product Portfolio
6.3.5 Oramed Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Company Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Antidiabetic Drug Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Company Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boehringer Ingelheim Antidiabetic Drug Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Company Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novo Nordisk Antidiabetic Drug Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Halozyme Therapeutics
6.7.1 Halozyme Therapeutics Company Information
6.7.2 Halozyme Therapeutics Description and Business Overview
6.7.3 Halozyme Therapeutics Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Halozyme Therapeutics Antidiabetic Drug Product Portfolio
6.7.5 Halozyme Therapeutics Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb Antidiabetic Drug Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Antidiabetic Drug Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Tonghua Dongbao
6.10.1 Tonghua Dongbao Company Information
6.10.2 Tonghua Dongbao Description and Business Overview
6.10.3 Tonghua Dongbao Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tonghua Dongbao Antidiabetic Drug Product Portfolio
6.10.5 Tonghua Dongbao Recent Developments/Updates
6.11 Biocon
6.11.1 Biocon Company Information
6.11.2 Biocon Description and Business Overview
6.11.3 Biocon Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biocon Antidiabetic Drug Product Portfolio
6.11.5 Biocon Recent Developments/Updates
6.12 Wockhardt
6.12.1 Wockhardt Company Information
6.12.2 Wockhardt Description and Business Overview
6.12.3 Wockhardt Antidiabetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Wockhardt Antidiabetic Drug Product Portfolio
6.12.5 Wockhardt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antidiabetic Drug Industry Chain Analysis
7.2 Antidiabetic Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antidiabetic Drug Production Mode & Process Analysis
7.4 Antidiabetic Drug Sales and Marketing
7.4.1 Antidiabetic Drug Sales Channels
7.4.2 Antidiabetic Drug Distributors
7.5 Antidiabetic Drug Customer Analysis
8 Antidiabetic Drug Market Dynamics
8.1 Antidiabetic Drug Industry Trends
8.2 Antidiabetic Drug Market Drivers
8.3 Antidiabetic Drug Market Challenges
8.4 Antidiabetic Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol–Myers Squibb
Pfizer Inc
Tonghua Dongbao
Biocon Ltd.
WOCKHARDT
List of Tables
 Table 1. Global Antidiabetic Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antidiabetic Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antidiabetic Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antidiabetic Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antidiabetic Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antidiabetic Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antidiabetic Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antidiabetic Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antidiabetic Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antidiabetic Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antidiabetic Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Antidiabetic Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antidiabetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetic Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antidiabetic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antidiabetic Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antidiabetic Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Antidiabetic Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antidiabetic Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Antidiabetic Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antidiabetic Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Antidiabetic Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antidiabetic Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Antidiabetic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antidiabetic Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antidiabetic Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antidiabetic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antidiabetic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antidiabetic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antidiabetic Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antidiabetic Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antidiabetic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antidiabetic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antidiabetic Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antidiabetic Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antidiabetic Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antidiabetic Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antidiabetic Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antidiabetic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antidiabetic Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antidiabetic Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antidiabetic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antidiabetic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antidiabetic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antidiabetic Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antidiabetic Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antidiabetic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antidiabetic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antidiabetic Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Antidiabetic Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Antidiabetic Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Antidiabetic Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Antidiabetic Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antidiabetic Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antidiabetic Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Antidiabetic Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Antidiabetic Drug Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Antidiabetic Drug Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Antidiabetic Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Antidiabetic Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Antidiabetic Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Antidiabetic Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Antidiabetic Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antidiabetic Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antidiabetic Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Antidiabetic Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Antidiabetic Drug Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Antidiabetic Drug Price (USD/Unit) by Application (2026-2031)
 Table 70. Sanofi-Aventis Company Information
 Table 71. Sanofi-Aventis Description and Business Overview
 Table 72. Sanofi-Aventis Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi-Aventis Antidiabetic Drug Product
 Table 74. Sanofi-Aventis Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lilly Antidiabetic Drug Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Oramed Company Information
 Table 81. Oramed Description and Business Overview
 Table 82. Oramed Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Oramed Antidiabetic Drug Product
 Table 84. Oramed Recent Developments/Updates
 Table 85. Takeda Company Information
 Table 86. Takeda Description and Business Overview
 Table 87. Takeda Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Takeda Antidiabetic Drug Product
 Table 89. Takeda Recent Developments/Updates
 Table 90. Boehringer Ingelheim Company Information
 Table 91. Boehringer Ingelheim Description and Business Overview
 Table 92. Boehringer Ingelheim Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Boehringer Ingelheim Antidiabetic Drug Product
 Table 94. Boehringer Ingelheim Recent Developments/Updates
 Table 95. Novo Nordisk Company Information
 Table 96. Novo Nordisk Description and Business Overview
 Table 97. Novo Nordisk Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Novo Nordisk Antidiabetic Drug Product
 Table 99. Novo Nordisk Recent Developments/Updates
 Table 100. Halozyme Therapeutics Company Information
 Table 101. Halozyme Therapeutics Description and Business Overview
 Table 102. Halozyme Therapeutics Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Halozyme Therapeutics Antidiabetic Drug Product
 Table 104. Halozyme Therapeutics Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb Antidiabetic Drug Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. Pfizer Company Information
 Table 111. Pfizer Description and Business Overview
 Table 112. Pfizer Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Pfizer Antidiabetic Drug Product
 Table 114. Pfizer Recent Developments/Updates
 Table 115. Tonghua Dongbao Company Information
 Table 116. Tonghua Dongbao Description and Business Overview
 Table 117. Tonghua Dongbao Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Tonghua Dongbao Antidiabetic Drug Product
 Table 119. Tonghua Dongbao Recent Developments/Updates
 Table 120. Biocon Company Information
 Table 121. Biocon Description and Business Overview
 Table 122. Biocon Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Biocon Antidiabetic Drug Product
 Table 124. Biocon Recent Developments/Updates
 Table 125. Wockhardt Company Information
 Table 126. Wockhardt Description and Business Overview
 Table 127. Wockhardt Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Wockhardt Antidiabetic Drug Product
 Table 129. Wockhardt Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Antidiabetic Drug Distributors List
 Table 133. Antidiabetic Drug Customers List
 Table 134. Antidiabetic Drug Market Trends
 Table 135. Antidiabetic Drug Market Drivers
 Table 136. Antidiabetic Drug Market Challenges
 Table 137. Antidiabetic Drug Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antidiabetic Drug
 Figure 2. Global Antidiabetic Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antidiabetic Drug Market Share by Type: 2024 & 2031
 Figure 4. Alpha-Glucosidase Inhibitors Product Picture
 Figure 5. Biguanides, Sulphonylureas Product Picture
 Figure 6. Glp-1 Agonist Product Picture
 Figure 7. Meglitinides Product Picture
 Figure 8. Dpp-4 Inhibitors Product Picture
 Figure 9. Sglt–2 Product Picture
 Figure 10. Thiazolodinediones Product Picture
 Figure 11. Global Antidiabetic Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Antidiabetic Drug Market Share by Application: 2024 & 2031
 Figure 13. Type I Diabetes
 Figure 14. Type II Diabetes
 Figure 15. Global Antidiabetic Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Antidiabetic Drug Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Antidiabetic Drug Sales (2020-2031) & (K Units)
 Figure 18. Global Antidiabetic Drug Average Price (USD/Unit) & (2020-2031)
 Figure 19. Antidiabetic Drug Report Years Considered
 Figure 20. Antidiabetic Drug Sales Share by Manufacturers in 2024
 Figure 21. Global Antidiabetic Drug Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Antidiabetic Drug Players: Market Share by Revenue in Antidiabetic Drug in 2024
 Figure 23. Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Antidiabetic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Antidiabetic Drug Sales Market Share by Country (2020-2031)
 Figure 26. North America Antidiabetic Drug Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Antidiabetic Drug Sales Market Share by Country (2020-2031)
 Figure 30. Europe Antidiabetic Drug Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Antidiabetic Drug Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Antidiabetic Drug Revenue Market Share by Region (2020-2031)
 Figure 38. China Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Antidiabetic Drug Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Antidiabetic Drug Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Antidiabetic Drug Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Antidiabetic Drug Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. U.A.E Antidiabetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Antidiabetic Drug by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Antidiabetic Drug by Type (2020-2031)
 Figure 60. Global Antidiabetic Drug Price (USD/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Antidiabetic Drug by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Antidiabetic Drug by Application (2020-2031)
 Figure 63. Global Antidiabetic Drug Price (USD/Unit) by Application (2020-2031)
 Figure 64. Antidiabetic Drug Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions